All Type of News
Government to get tough over GMP and rebate provision
Vowing to upgrade the quality of pharmaceutical products through more expanded implementation of new Good Manufacturing Practice (GMP) system next year, the Ministry of Health, Welfare and Family Affairs announced its...
Korean drugmakers set eyes on overseas markets
The domestic major pharmaceutical firms, such as Dong-A Pharmaceutical, Yuhan Corporation and Hanmi Pharm, are going all-out to make inroads into foreign countries as the domestic market shows clear signs of reaching ...
KFDA to strengthen food and drug safety regulations
The Korea Food and Drug Administration (KFDA) said on December 24 that it would toughen rules on food and drug safety, while going ahead with drastic deregulation measures, according to data reported to President Lee ...
Pharmaceutical firms to raise R&D spending by 10% in 2012
Domestic pharmaceutical firms plan to hike spending on research and development (R&D) by 10 percent over their sales revenue from six percent this year.
In his New Year message, the Korea Pharmaceutical Manufacture...
Samjin’s pyrimidinediones to enter Phase I clinical trials
Samjin Pharmaceutical, in collaboration with their drug development partner, the US based ImQuest Pharmaceutical Inc., have recently engaged in an effort to develop more active pyrimidinediones possessing this higher ...
Dong-A to face tough challenge next year
The race for the generic drug market is set to be in full force in 2009.
The drug recently at the center of attention is the best-selling Stillen, a gastric membrane protector that will generate about 80 billion in...
High-priced 693 items to be re-evaluated in 2009
The Korea Insurance Review and Assessment Service announced on December 23 that it will re-evaluate the economic effectiveness of expensive 693 drugs (583 ingredients) in the first quarter of next year, down 77 items ...
Government mulls linkage system between license and insurance price in 2009
The government plans to introduce a linkage system of assessing the possible health insurance prices of chemically modified drugs and/or generic products simultaneously along with the drug approval process by the Kore...
Wyeth Korea accepts pay deal
Union members of Wyeth Korea agreed to accept a pay deal agreement on December 23 that had been struck between union leaders and management for 57 days.
Roughly 70 percent of union members voted for the 9.3 percent...
Chunggei launches pioglitazone 15 mg
Chunggei Pharm has launched pioglitazone 15 mg in a bid to expand its presence in domestic type 2 diabetes market under joint marketing with Schnell Pharmaceuticals Inc.
Pioglitazone is used with a diet and exerci...
